NOX2 or NOX4 is often activated in ovarian cancer and renal cell carcinoma through the Hippo pathway effector tafazzin (TAZ), promoting erastin-induced ferroptosis [54,55]. This evidence concerns the gene TAFAZZIN and renal cell carcinoma.